A large number of studies show that activation of the ErbB family of receptors (particularly EGFR/HER1, HER2, and HER3) plays pivotal roles in the development, pathogenesis, and behavior of NSCLC cells [72]. Here, ERBB2 is linked to non-small cell lung carcinoma.